Jefferies Financial Group reissued their hold rating on shares of Reckitt Benckiser Group (LON:RKT – Free Report) in a research report sent to investors on Monday, Marketbeat reports. They currently have a GBX 4,400 ($56.60) price target on the stock.
Several other brokerages have also recently issued reports on RKT. Berenberg Bank lifted their target price on Reckitt Benckiser Group from GBX 5,100 ($65.60) to GBX 5,200 ($66.89) and gave the company a hold rating in a research report on Wednesday, July 24th. HSBC reaffirmed a hold rating on shares of Reckitt Benckiser Group in a research report on Thursday, April 18th.
Read Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 0.0 %
Reckitt Benckiser Group Cuts Dividend
The firm also recently declared a dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 1st will be issued a dividend of GBX 80.40 ($1.03) per share. The ex-dividend date of this dividend is Thursday, August 1st. This represents a yield of 1.82%. Reckitt Benckiser Group’s dividend payout ratio (DPR) is currently 8,502.20%.
Insider Buying and Selling
In other Reckitt Benckiser Group news, insider Tamara Ingram purchased 350 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were acquired at an average cost of GBX 4,509 ($58.00) per share, for a total transaction of £15,781.50 ($20,300.36). 0.07% of the stock is currently owned by corporate insiders.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- The How And Why of Investing in Oil Stocks
- First Solar Stock: The Dawn of a New Rally in Share Prices
- P/E Ratio Calculation: How to Assess Stocks
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Stock Average Calculator
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.